PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Stat2
|
ENSMUSG00000040033.17 | Stat2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Stat2 | mm39_v1_chr10_+_128106414_128106446 | 0.74 | 7.1e-14 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_+_78141679 | 30.97 |
ENSMUST00000022591.16
ENSMUST00000169978.2 ENSMUST00000227903.2 |
Epsti1
|
epithelial stromal interaction 1 (breast) |
chr11_-_83421333 | 24.93 |
ENSMUST00000035938.3
|
Ccl5
|
chemokine (C-C motif) ligand 5 |
chr12_-_26506422 | 24.10 |
ENSMUST00000020970.10
|
Rsad2
|
radical S-adenosyl methionine domain containing 2 |
chrX_-_9335525 | 20.35 |
ENSMUST00000015484.10
|
Cybb
|
cytochrome b-245, beta polypeptide |
chr6_+_121222865 | 20.15 |
ENSMUST00000032198.11
|
Usp18
|
ubiquitin specific peptidase 18 |
chr1_-_173318607 | 19.41 |
ENSMUST00000160565.4
|
Ifi206
|
interferon activated gene 206 |
chr7_-_104114384 | 18.95 |
ENSMUST00000076922.6
|
Trim30a
|
tripartite motif-containing 30A |
chr1_-_173426640 | 18.60 |
ENSMUST00000150649.9
ENSMUST00000180215.2 ENSMUST00000097462.9 |
Ifi213
|
interferon activated gene 213 |
chr15_-_77417512 | 17.72 |
ENSMUST00000062562.7
ENSMUST00000230863.2 |
Apol7c
|
apolipoprotein L 7c |
chr1_+_173501215 | 17.32 |
ENSMUST00000085876.12
|
Ifi208
|
interferon activated gene 208 |
chr4_-_156285247 | 17.28 |
ENSMUST00000085425.6
|
Isg15
|
ISG15 ubiquitin-like modifier |
chr2_-_173060647 | 17.27 |
ENSMUST00000109116.3
ENSMUST00000029018.14 |
Zbp1
|
Z-DNA binding protein 1 |
chr1_+_170846482 | 17.23 |
ENSMUST00000078825.5
|
Fcgr4
|
Fc receptor, IgG, low affinity IV |
chr1_-_173770010 | 17.16 |
ENSMUST00000042228.15
ENSMUST00000081216.12 ENSMUST00000129829.8 ENSMUST00000123708.8 |
Ifi203
|
interferon activated gene 203 |
chr7_+_142014546 | 16.91 |
ENSMUST00000105968.8
ENSMUST00000018963.11 ENSMUST00000105967.8 |
Lsp1
|
lymphocyte specific 1 |
chr1_-_85526517 | 16.88 |
ENSMUST00000093508.7
|
Sp110
|
Sp110 nuclear body protein |
chr7_-_104157006 | 16.75 |
ENSMUST00000033211.14
ENSMUST00000071069.13 |
Trim30d
|
tripartite motif-containing 30D |
chr1_-_173707677 | 16.71 |
ENSMUST00000190651.4
ENSMUST00000188804.7 |
Mndal
|
myeloid nuclear differentiation antigen like |
chr4_-_46536088 | 16.69 |
ENSMUST00000102924.3
ENSMUST00000046897.13 |
Trim14
|
tripartite motif-containing 14 |
chr17_+_34406523 | 16.66 |
ENSMUST00000170086.8
|
Tap1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr1_+_85577709 | 16.65 |
ENSMUST00000155094.8
ENSMUST00000054279.15 ENSMUST00000147552.8 ENSMUST00000153574.8 ENSMUST00000150967.8 |
Sp100
|
nuclear antigen Sp100 |
chr17_-_34406193 | 16.63 |
ENSMUST00000173831.3
|
Psmb9
|
proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2) |
chr1_+_85577766 | 16.61 |
ENSMUST00000066427.11
|
Sp100
|
nuclear antigen Sp100 |
chr4_-_42773987 | 16.57 |
ENSMUST00000095114.5
|
Ccl21a
|
chemokine (C-C motif) ligand 21A (serine) |
chr9_+_107852733 | 16.41 |
ENSMUST00000035216.11
|
Uba7
|
ubiquitin-like modifier activating enzyme 7 |
chr15_+_79776597 | 16.09 |
ENSMUST00000175714.8
ENSMUST00000109620.10 ENSMUST00000165537.8 ENSMUST00000175752.8 ENSMUST00000176325.8 |
Apobec3
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 3 |
chr7_-_140590605 | 16.07 |
ENSMUST00000026565.7
|
Ifitm3
|
interferon induced transmembrane protein 3 |
chr4_-_155013002 | 16.05 |
ENSMUST00000152687.8
ENSMUST00000137803.8 ENSMUST00000145296.2 |
Tnfrsf14
|
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
chr6_+_145067457 | 16.00 |
ENSMUST00000032396.13
|
Lrmp
|
lymphoid-restricted membrane protein |
chr1_-_173859321 | 15.43 |
ENSMUST00000059226.7
|
Ifi205
|
interferon activated gene 205 |
chr19_+_34618271 | 15.33 |
ENSMUST00000102824.4
|
Ifit1
|
interferon-induced protein with tetratricopeptide repeats 1 |
chr11_+_46701619 | 15.29 |
ENSMUST00000068877.7
|
Timd4
|
T cell immunoglobulin and mucin domain containing 4 |
chr7_-_140846328 | 15.17 |
ENSMUST00000106023.8
ENSMUST00000097952.9 ENSMUST00000026571.11 |
Irf7
|
interferon regulatory factor 7 |
chr17_+_34406762 | 15.03 |
ENSMUST00000041633.15
|
Tap1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr13_+_120761861 | 14.88 |
ENSMUST00000225029.2
|
BC147527
|
cDNA sequence BC147527 |
chr10_+_51367052 | 14.73 |
ENSMUST00000217705.2
ENSMUST00000078778.5 ENSMUST00000220182.2 ENSMUST00000220226.2 |
Lilrb4a
|
leukocyte immunoglobulin-like receptor, subfamily B, member 4A |
chr1_-_173740467 | 14.40 |
ENSMUST00000009340.10
|
Ifi211
|
interferon activated gene 211 |
chr19_+_12438125 | 14.04 |
ENSMUST00000081035.9
|
Mpeg1
|
macrophage expressed gene 1 |
chr6_+_39358036 | 14.02 |
ENSMUST00000031986.5
|
Rab19
|
RAB19, member RAS oncogene family |
chr4_-_42756489 | 13.97 |
ENSMUST00000140546.3
ENSMUST00000102957.6 |
Ccl19
|
chemokine (C-C motif) ligand 19 |
chr5_-_121045568 | 13.96 |
ENSMUST00000080322.8
|
Oas1a
|
2'-5' oligoadenylate synthetase 1A |
chr1_+_175459559 | 13.93 |
ENSMUST00000040250.15
|
Kmo
|
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
chr16_+_10306075 | 13.31 |
ENSMUST00000023147.8
|
Ciita
|
class II transactivator |
chr19_+_10819896 | 13.21 |
ENSMUST00000025646.3
|
Slc15a3
|
solute carrier family 15, member 3 |
chr1_+_34511793 | 13.07 |
ENSMUST00000188972.3
|
Ptpn18
|
protein tyrosine phosphatase, non-receptor type 18 |
chr1_-_173594475 | 12.98 |
ENSMUST00000111214.4
|
Ifi204
|
interferon activated gene 204 |
chr4_-_155012534 | 12.92 |
ENSMUST00000219534.3
|
Tnfrsf14
|
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
chr3_-_14843512 | 12.85 |
ENSMUST00000094365.11
|
Car1
|
carbonic anhydrase 1 |
chr7_+_78563184 | 12.83 |
ENSMUST00000121645.8
|
Isg20
|
interferon-stimulated protein |
chr11_-_78875689 | 12.83 |
ENSMUST00000108269.10
ENSMUST00000108268.10 |
Lgals9
|
lectin, galactose binding, soluble 9 |
chr6_+_41498716 | 12.50 |
ENSMUST00000070380.5
|
Prss2
|
protease, serine 2 |
chr15_-_77527470 | 12.38 |
ENSMUST00000181154.2
ENSMUST00000180949.8 ENSMUST00000166623.10 |
Apol11b
|
apolipoprotein L 11b |
chr11_+_88890202 | 12.37 |
ENSMUST00000100627.9
ENSMUST00000107896.10 ENSMUST00000000284.7 |
Trim25
|
tripartite motif-containing 25 |
chr16_-_35691914 | 12.36 |
ENSMUST00000042665.9
|
Parp14
|
poly (ADP-ribose) polymerase family, member 14 |
chr11_-_48870105 | 12.28 |
ENSMUST00000141200.2
ENSMUST00000097494.9 ENSMUST00000093153.2 |
9930111J21Rik1
|
RIKEN cDNA 9930111J21 gene 1 |
chr18_+_60515755 | 12.23 |
ENSMUST00000237185.2
|
Iigp1
|
interferon inducible GTPase 1 |
chr7_+_78563513 | 12.22 |
ENSMUST00000038142.15
|
Isg20
|
interferon-stimulated protein |
chr5_-_120915693 | 12.13 |
ENSMUST00000044833.9
|
Oas3
|
2'-5' oligoadenylate synthetase 3 |
chr2_-_180883813 | 12.04 |
ENSMUST00000094203.11
ENSMUST00000108831.8 |
Helz2
|
helicase with zinc finger 2, transcriptional coactivator |
chr6_+_29529275 | 11.93 |
ENSMUST00000163511.7
|
Irf5
|
interferon regulatory factor 5 |
chr7_-_140535899 | 11.92 |
ENSMUST00000081649.10
|
Ifitm2
|
interferon induced transmembrane protein 2 |
chr1_-_173363523 | 11.86 |
ENSMUST00000139092.8
|
Ifi214
|
interferon activated gene 214 |
chr11_-_48941949 | 11.74 |
ENSMUST00000132768.2
ENSMUST00000101295.9 ENSMUST00000093152.2 |
9930111J21Rik2
|
RIKEN cDNA 9930111J21 gene 2 |
chr5_-_120887864 | 11.70 |
ENSMUST00000053909.13
ENSMUST00000081491.13 |
Oas2
|
2'-5' oligoadenylate synthetase 2 |
chr13_+_37529184 | 11.70 |
ENSMUST00000021860.7
|
Ly86
|
lymphocyte antigen 86 |
chr11_-_82911615 | 11.67 |
ENSMUST00000038141.15
ENSMUST00000092838.11 |
Slfn8
|
schlafen 8 |
chr1_+_175459735 | 11.66 |
ENSMUST00000097458.4
|
Kmo
|
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
chr7_+_78563964 | 11.65 |
ENSMUST00000120331.4
|
Isg20
|
interferon-stimulated protein |
chr11_-_78875657 | 11.64 |
ENSMUST00000073001.5
|
Lgals9
|
lectin, galactose binding, soluble 9 |
chr16_+_35758836 | 11.62 |
ENSMUST00000114878.8
|
Parp9
|
poly (ADP-ribose) polymerase family, member 9 |
chr7_+_43057611 | 11.56 |
ENSMUST00000005592.7
|
Siglecg
|
sialic acid binding Ig-like lectin G |
chr8_-_71990085 | 11.37 |
ENSMUST00000051672.9
|
Bst2
|
bone marrow stromal cell antigen 2 |
chr11_+_58090382 | 11.34 |
ENSMUST00000035266.11
ENSMUST00000094169.11 ENSMUST00000168280.2 ENSMUST00000058704.9 |
Igtp
Irgm2
|
interferon gamma induced GTPase immunity-related GTPase family M member 2 |
chr2_-_180883746 | 11.17 |
ENSMUST00000121484.2
|
Helz2
|
helicase with zinc finger 2, transcriptional coactivator |
chr4_-_155012643 | 10.88 |
ENSMUST00000123514.8
|
Tnfrsf14
|
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
chr7_+_103893658 | 10.81 |
ENSMUST00000106849.9
ENSMUST00000060315.12 |
Trim34a
|
tripartite motif-containing 34A |
chr14_+_55842002 | 10.81 |
ENSMUST00000138037.2
|
Irf9
|
interferon regulatory factor 9 |
chr18_+_60345152 | 10.78 |
ENSMUST00000031549.6
|
Gm4951
|
predicted gene 4951 |
chr17_-_35081129 | 10.61 |
ENSMUST00000154526.8
|
Cfb
|
complement factor B |
chr8_+_67947494 | 10.30 |
ENSMUST00000093470.7
ENSMUST00000163856.3 |
Nat2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
chr7_+_78564062 | 10.28 |
ENSMUST00000205981.2
|
Isg20
|
interferon-stimulated protein |
chr15_-_76127600 | 10.18 |
ENSMUST00000165738.8
ENSMUST00000075689.7 |
Parp10
|
poly (ADP-ribose) polymerase family, member 10 |
chr6_+_128339882 | 10.17 |
ENSMUST00000073316.13
|
Foxm1
|
forkhead box M1 |
chr16_+_35759346 | 10.10 |
ENSMUST00000023622.13
|
Parp9
|
poly (ADP-ribose) polymerase family, member 9 |
chr16_+_23428650 | 10.08 |
ENSMUST00000038423.6
ENSMUST00000211349.2 |
Rtp4
|
receptor transporter protein 4 |
chr11_-_82911548 | 9.85 |
ENSMUST00000108152.9
|
Slfn8
|
schlafen 8 |
chr7_+_44485704 | 9.81 |
ENSMUST00000033015.8
|
Il4i1
|
interleukin 4 induced 1 |
chr14_+_14475188 | 9.77 |
ENSMUST00000026315.8
|
Dnase1l3
|
deoxyribonuclease 1-like 3 |
chr11_+_106642052 | 9.72 |
ENSMUST00000147326.9
ENSMUST00000182896.8 ENSMUST00000182908.8 ENSMUST00000086353.11 |
Milr1
|
mast cell immunoglobulin like receptor 1 |
chr8_+_72943455 | 9.52 |
ENSMUST00000072097.14
|
Hsh2d
|
hematopoietic SH2 domain containing |
chr7_-_140535828 | 9.48 |
ENSMUST00000211129.2
|
Gm45717
|
predicted gene 45717 |
chr7_+_103893672 | 9.42 |
ENSMUST00000106848.8
|
Trim34a
|
tripartite motif-containing 34A |
chr8_-_112064783 | 9.38 |
ENSMUST00000056157.14
ENSMUST00000120432.3 |
Mlkl
|
mixed lineage kinase domain-like |
chr10_+_87696339 | 9.38 |
ENSMUST00000121161.8
|
Igf1
|
insulin-like growth factor 1 |
chr3_-_136031799 | 9.37 |
ENSMUST00000196159.5
ENSMUST00000041577.13 |
Bank1
|
B cell scaffold protein with ankyrin repeats 1 |
chr9_-_58156982 | 9.37 |
ENSMUST00000135310.8
ENSMUST00000085673.11 ENSMUST00000114136.9 ENSMUST00000153820.8 ENSMUST00000124982.2 |
Pml
|
promyelocytic leukemia |
chrX_+_84913911 | 9.34 |
ENSMUST00000113976.2
|
Tasl
|
TLR adaptor interacting with endolysosomal SLC15A4 |
chr1_-_173569301 | 9.32 |
ENSMUST00000042610.15
ENSMUST00000127730.2 |
Ifi207
|
interferon activated gene 207 |
chr17_+_75772475 | 9.31 |
ENSMUST00000095204.6
|
Rasgrp3
|
RAS, guanyl releasing protein 3 |
chr16_-_10603389 | 9.21 |
ENSMUST00000229866.2
ENSMUST00000038099.6 |
Socs1
|
suppressor of cytokine signaling 1 |
chr11_-_118292758 | 9.13 |
ENSMUST00000043722.10
|
Lgals3bp
|
lectin, galactoside-binding, soluble, 3 binding protein |
chr11_-_100595019 | 9.08 |
ENSMUST00000017974.13
|
Dhx58
|
DEXH (Asp-Glu-X-His) box polypeptide 58 |
chr11_-_48883053 | 8.99 |
ENSMUST00000059930.3
ENSMUST00000068063.4 |
Gm12185
Tgtp1
|
predicted gene 12185 T cell specific GTPase 1 |
chr5_-_121025645 | 8.77 |
ENSMUST00000086368.12
|
Oas1g
|
2'-5' oligoadenylate synthetase 1G |
chr7_-_102214636 | 8.76 |
ENSMUST00000106913.3
ENSMUST00000033264.12 |
Trim21
|
tripartite motif-containing 21 |
chr17_-_35392254 | 8.69 |
ENSMUST00000025257.12
|
Aif1
|
allograft inflammatory factor 1 |
chr16_-_35759461 | 8.64 |
ENSMUST00000081933.14
ENSMUST00000114885.3 |
Dtx3l
|
deltex 3-like, E3 ubiquitin ligase |
chr13_+_74787952 | 8.64 |
ENSMUST00000221822.2
ENSMUST00000221526.2 |
Erap1
|
endoplasmic reticulum aminopeptidase 1 |
chr18_-_78185334 | 8.61 |
ENSMUST00000160639.2
|
Slc14a1
|
solute carrier family 14 (urea transporter), member 1 |
chr2_-_51862941 | 8.47 |
ENSMUST00000145481.8
ENSMUST00000112705.9 |
Nmi
|
N-myc (and STAT) interactor |
chr3_-_7678785 | 8.47 |
ENSMUST00000194279.6
|
Il7
|
interleukin 7 |
chr15_-_66684442 | 8.46 |
ENSMUST00000100572.10
|
Sla
|
src-like adaptor |
chr10_-_43880353 | 8.19 |
ENSMUST00000020017.14
|
Crybg1
|
crystallin beta-gamma domain containing 1 |
chr11_-_118292678 | 8.14 |
ENSMUST00000106290.4
|
Lgals3bp
|
lectin, galactoside-binding, soluble, 3 binding protein |
chr2_+_121978156 | 8.12 |
ENSMUST00000102476.5
|
B2m
|
beta-2 microglobulin |
chr3_+_60408600 | 8.08 |
ENSMUST00000099087.8
|
Mbnl1
|
muscleblind like splicing factor 1 |
chr1_+_171216480 | 8.04 |
ENSMUST00000056449.9
|
Arhgap30
|
Rho GTPase activating protein 30 |
chr13_-_100338469 | 8.01 |
ENSMUST00000167986.3
ENSMUST00000117913.8 |
Naip2
|
NLR family, apoptosis inhibitory protein 2 |
chr3_-_7678796 | 8.00 |
ENSMUST00000192202.6
|
Il7
|
interleukin 7 |
chr6_-_38331187 | 7.77 |
ENSMUST00000114900.8
ENSMUST00000143702.5 |
Zc3hav1
|
zinc finger CCCH type, antiviral 1 |
chr9_-_58156935 | 7.52 |
ENSMUST00000124063.2
ENSMUST00000126690.8 |
Pml
|
promyelocytic leukemia |
chr14_+_55815999 | 7.45 |
ENSMUST00000172738.2
ENSMUST00000089619.13 |
Psme1
|
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) |
chr19_+_34560922 | 7.43 |
ENSMUST00000102825.4
|
Ifit3
|
interferon-induced protein with tetratricopeptide repeats 3 |
chr11_+_106642079 | 7.40 |
ENSMUST00000183111.8
ENSMUST00000106794.9 |
Milr1
|
mast cell immunoglobulin like receptor 1 |
chr11_-_70350783 | 7.39 |
ENSMUST00000019064.9
|
Cxcl16
|
chemokine (C-X-C motif) ligand 16 |
chr3_-_151455514 | 7.38 |
ENSMUST00000029671.9
|
Ifi44
|
interferon-induced protein 44 |
chr5_-_92496730 | 7.33 |
ENSMUST00000038816.13
ENSMUST00000118006.3 |
Cxcl10
|
chemokine (C-X-C motif) ligand 10 |
chr10_+_87695886 | 7.24 |
ENSMUST00000062862.13
|
Igf1
|
insulin-like growth factor 1 |
chr15_+_77613239 | 7.23 |
ENSMUST00000230979.2
ENSMUST00000109775.4 |
Apol9b
|
apolipoprotein L 9b |
chr11_-_82882613 | 7.13 |
ENSMUST00000092840.11
ENSMUST00000038211.13 |
Slfn9
|
schlafen 9 |
chr10_-_94780695 | 7.10 |
ENSMUST00000099337.5
|
Plxnc1
|
plexin C1 |
chr19_+_6214416 | 7.07 |
ENSMUST00000045042.8
ENSMUST00000237511.2 |
Batf2
|
basic leucine zipper transcription factor, ATF-like 2 |
chr17_-_35081456 | 6.86 |
ENSMUST00000025229.11
ENSMUST00000176203.9 ENSMUST00000128767.8 |
Cfb
|
complement factor B |
chr13_-_56326695 | 6.85 |
ENSMUST00000225063.2
|
Tifab
|
TRAF-interacting protein with forkhead-associated domain, family member B |
chr5_-_137145030 | 6.84 |
ENSMUST00000054384.6
ENSMUST00000152207.2 |
Trim56
|
tripartite motif-containing 56 |
chr9_+_118307412 | 6.83 |
ENSMUST00000035020.15
|
Eomes
|
eomesodermin |
chr14_+_55815879 | 6.78 |
ENSMUST00000174563.8
|
Psme1
|
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) |
chr13_-_56326511 | 6.76 |
ENSMUST00000169652.3
|
Tifab
|
TRAF-interacting protein with forkhead-associated domain, family member B |
chrX_+_41239872 | 6.75 |
ENSMUST00000123245.8
|
Stag2
|
stromal antigen 2 |
chr3_+_60408678 | 6.75 |
ENSMUST00000191747.6
ENSMUST00000194069.6 |
Mbnl1
|
muscleblind like splicing factor 1 |
chr7_-_101667346 | 6.65 |
ENSMUST00000209844.2
ENSMUST00000211502.2 ENSMUST00000094134.5 |
Il18bp
|
interleukin 18 binding protein |
chr17_+_34354556 | 6.62 |
ENSMUST00000236322.2
ENSMUST00000237402.2 |
H2-DMa
|
histocompatibility 2, class II, locus DMa |
chr3_-_136031723 | 6.61 |
ENSMUST00000198206.2
|
Bank1
|
B cell scaffold protein with ankyrin repeats 1 |
chr9_-_106353571 | 6.61 |
ENSMUST00000123555.8
ENSMUST00000125850.2 |
Parp3
|
poly (ADP-ribose) polymerase family, member 3 |
chr11_-_48762170 | 6.59 |
ENSMUST00000049519.4
ENSMUST00000097271.4 |
Irgm1
|
immunity-related GTPase family M member 1 |
chr1_+_85454323 | 6.58 |
ENSMUST00000239236.2
|
Gm7592
|
predicted gene 7592 |
chr14_+_54429757 | 6.43 |
ENSMUST00000103714.2
|
Traj27
|
T cell receptor alpha joining 27 |
chr1_-_184464810 | 6.40 |
ENSMUST00000048572.7
|
Hlx
|
H2.0-like homeobox |
chr14_+_55815817 | 6.38 |
ENSMUST00000174259.8
|
Psme1
|
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) |
chr1_+_52158599 | 6.36 |
ENSMUST00000186574.7
ENSMUST00000070968.14 ENSMUST00000191435.7 ENSMUST00000186857.7 ENSMUST00000188681.7 |
Stat1
|
signal transducer and activator of transcription 1 |
chr19_+_56385531 | 6.17 |
ENSMUST00000026062.10
|
Casp7
|
caspase 7 |
chr5_+_115034997 | 6.00 |
ENSMUST00000031542.13
ENSMUST00000146072.8 ENSMUST00000150361.2 |
Oasl2
|
2'-5' oligoadenylate synthetase-like 2 |
chr9_+_96141317 | 5.96 |
ENSMUST00000165768.4
|
Tfdp2
|
transcription factor Dp 2 |
chr3_+_27371168 | 5.94 |
ENSMUST00000046383.12
|
Tnfsf10
|
tumor necrosis factor (ligand) superfamily, member 10 |
chr9_+_96141299 | 5.93 |
ENSMUST00000179065.8
|
Tfdp2
|
transcription factor Dp 2 |
chr3_-_137687284 | 5.92 |
ENSMUST00000136613.4
ENSMUST00000029806.13 |
Dapp1
|
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
chr5_-_134258435 | 5.90 |
ENSMUST00000016094.13
ENSMUST00000111275.8 ENSMUST00000144086.2 |
Ncf1
|
neutrophil cytosolic factor 1 |
chr1_+_52158693 | 5.89 |
ENSMUST00000189347.7
|
Stat1
|
signal transducer and activator of transcription 1 |
chr3_+_127584449 | 5.87 |
ENSMUST00000171621.3
|
Tifa
|
TRAF-interacting protein with forkhead-associated domain |
chr3_+_127584251 | 5.86 |
ENSMUST00000164447.3
|
Tifa
|
TRAF-interacting protein with forkhead-associated domain |
chr4_+_94627513 | 5.85 |
ENSMUST00000073939.13
ENSMUST00000102798.8 |
Tek
|
TEK receptor tyrosine kinase |
chr17_-_79190002 | 5.81 |
ENSMUST00000024884.5
|
Eif2ak2
|
eukaryotic translation initiation factor 2-alpha kinase 2 |
chr19_+_3372296 | 5.76 |
ENSMUST00000237938.2
|
Cpt1a
|
carnitine palmitoyltransferase 1a, liver |
chr7_+_100742070 | 5.68 |
ENSMUST00000208439.2
|
Fchsd2
|
FCH and double SH3 domains 2 |
chr19_+_29388312 | 5.65 |
ENSMUST00000112576.4
|
Pdcd1lg2
|
programmed cell death 1 ligand 2 |
chr19_-_34579356 | 5.25 |
ENSMUST00000168254.3
|
Ifit1bl1
|
interferon induced protein with tetratricpeptide repeats 1B like 1 |
chr17_+_34138611 | 5.21 |
ENSMUST00000234247.2
|
Tapbp
|
TAP binding protein |
chr7_-_25488060 | 5.16 |
ENSMUST00000002677.11
ENSMUST00000085948.11 |
Axl
|
AXL receptor tyrosine kinase |
chr12_-_79054050 | 5.13 |
ENSMUST00000056660.13
ENSMUST00000174721.8 |
Tmem229b
|
transmembrane protein 229B |
chr14_+_55815580 | 5.11 |
ENSMUST00000174484.8
|
Psme1
|
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) |
chr3_+_142266113 | 5.06 |
ENSMUST00000106221.8
|
Gbp3
|
guanylate binding protein 3 |
chr5_+_43673093 | 5.03 |
ENSMUST00000144558.3
|
C1qtnf7
|
C1q and tumor necrosis factor related protein 7 |
chr1_+_153625243 | 5.01 |
ENSMUST00000182722.8
|
Rnasel
|
ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) |
chr14_+_40827108 | 5.00 |
ENSMUST00000224514.2
|
Mat1a
|
methionine adenosyltransferase I, alpha |
chr4_+_42255693 | 4.99 |
ENSMUST00000178864.3
|
Ccl21b
|
chemokine (C-C motif) ligand 21B (leucine) |
chr11_+_31822211 | 4.97 |
ENSMUST00000020543.13
ENSMUST00000109412.9 |
Cpeb4
|
cytoplasmic polyadenylation element binding protein 4 |
chr15_-_98816012 | 4.95 |
ENSMUST00000023736.10
|
Lmbr1l
|
limb region 1 like |
chr16_+_24212284 | 4.93 |
ENSMUST00000038053.14
|
Lpp
|
LIM domain containing preferred translocation partner in lipoma |
chr1_+_52158721 | 4.92 |
ENSMUST00000186057.7
|
Stat1
|
signal transducer and activator of transcription 1 |
chr1_+_153625161 | 4.85 |
ENSMUST00000086209.10
|
Rnasel
|
ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) |
chr17_+_34138699 | 4.83 |
ENSMUST00000234320.2
|
Tapbp
|
TAP binding protein |
chr12_-_80307110 | 4.82 |
ENSMUST00000021554.16
|
Actn1
|
actinin, alpha 1 |
chr9_-_106353303 | 4.79 |
ENSMUST00000156426.8
|
Parp3
|
poly (ADP-ribose) polymerase family, member 3 |
chr6_-_38331482 | 4.78 |
ENSMUST00000031850.10
ENSMUST00000114898.3 |
Zc3hav1
|
zinc finger CCCH type, antiviral 1 |
chr4_+_42114817 | 4.78 |
ENSMUST00000098123.4
|
Gm13304
|
predicted gene 13304 |
chr13_-_100454182 | 4.72 |
ENSMUST00000118574.8
|
Naip6
|
NLR family, apoptosis inhibitory protein 6 |
chr11_+_119283887 | 4.70 |
ENSMUST00000093902.12
ENSMUST00000131035.10 |
Rnf213
|
ring finger protein 213 |
chr4_-_136626073 | 4.63 |
ENSMUST00000046285.6
|
C1qa
|
complement component 1, q subcomponent, alpha polypeptide |
chr3_+_20011201 | 4.60 |
ENSMUST00000091309.12
ENSMUST00000108329.8 ENSMUST00000003714.13 |
Cp
|
ceruloplasmin |
chr19_+_29344846 | 4.60 |
ENSMUST00000016640.8
|
Cd274
|
CD274 antigen |
chr3_-_59038031 | 4.59 |
ENSMUST00000091112.6
ENSMUST00000065220.13 |
P2ry14
|
purinergic receptor P2Y, G-protein coupled, 14 |
chr11_+_115725140 | 4.58 |
ENSMUST00000173289.8
ENSMUST00000137900.2 |
Llgl2
|
LLGL2 scribble cell polarity complex component |
chr4_+_41903610 | 4.56 |
ENSMUST00000098128.4
|
Ccl21d
|
chemokine (C-C motif) ligand 21D |
chr8_-_45786226 | 4.53 |
ENSMUST00000095328.6
|
Cyp4v3
|
cytochrome P450, family 4, subfamily v, polypeptide 3 |
chr18_-_39623698 | 4.52 |
ENSMUST00000115567.8
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1 |
chr3_+_20011251 | 4.51 |
ENSMUST00000108328.8
|
Cp
|
ceruloplasmin |
chr3_+_142265904 | 4.46 |
ENSMUST00000128609.8
ENSMUST00000029935.14 |
Gbp3
|
guanylate binding protein 3 |
chr2_-_132095146 | 4.45 |
ENSMUST00000028817.7
|
Pcna
|
proliferating cell nuclear antigen |
chr3_-_144425819 | 4.44 |
ENSMUST00000199531.5
ENSMUST00000199854.5 |
Sh3glb1
|
SH3-domain GRB2-like B1 (endophilin) |
chr17_+_75772567 | 4.43 |
ENSMUST00000234660.2
|
Rasgrp3
|
RAS, guanyl releasing protein 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.6 | 31.7 | GO:0046967 | cytosol to ER transport(GO:0046967) |
10.2 | 30.5 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
7.8 | 47.0 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
6.2 | 24.9 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
6.0 | 24.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
5.7 | 17.2 | GO:0034240 | negative regulation of macrophage fusion(GO:0034240) |
5.6 | 22.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
4.9 | 24.5 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
4.5 | 13.6 | GO:0071626 | mastication(GO:0071626) learned vocalization behavior(GO:0098583) |
4.3 | 25.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
4.2 | 33.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
4.1 | 12.4 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
4.1 | 8.1 | GO:0002477 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
3.9 | 11.7 | GO:0009087 | methionine catabolic process(GO:0009087) |
3.8 | 11.3 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
2.9 | 8.7 | GO:0014739 | positive regulation of muscle hyperplasia(GO:0014739) |
2.8 | 39.8 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
2.8 | 11.1 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
2.7 | 19.0 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
2.7 | 77.7 | GO:0035455 | response to interferon-alpha(GO:0035455) |
2.5 | 20.4 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
2.5 | 15.2 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
2.5 | 30.2 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
2.5 | 10.0 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
2.5 | 37.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
2.4 | 16.6 | GO:1904073 | regulation of oligodendrocyte apoptotic process(GO:1900141) negative regulation of oligodendrocyte apoptotic process(GO:1900142) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
2.3 | 13.8 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
2.2 | 6.6 | GO:0002501 | MHC protein complex assembly(GO:0002396) peptide antigen assembly with MHC protein complex(GO:0002501) |
2.0 | 91.7 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
2.0 | 5.9 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
1.8 | 7.3 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
1.8 | 1.8 | GO:0035456 | response to interferon-beta(GO:0035456) |
1.7 | 15.4 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
1.7 | 8.4 | GO:0035546 | detection of virus(GO:0009597) interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
1.7 | 8.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
1.6 | 9.5 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
1.5 | 12.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
1.5 | 9.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
1.5 | 4.4 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
1.5 | 11.7 | GO:0018377 | protein myristoylation(GO:0018377) |
1.5 | 4.4 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.4 | 8.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.4 | 10.0 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
1.4 | 17.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
1.3 | 16.0 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
1.3 | 6.4 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
1.3 | 5.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
1.3 | 8.8 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
1.3 | 12.5 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
1.2 | 6.2 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
1.2 | 5.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.1 | 4.6 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
1.1 | 5.6 | GO:0035723 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
1.1 | 4.4 | GO:0006272 | leading strand elongation(GO:0006272) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
1.1 | 10.7 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
1.1 | 10.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.0 | 3.1 | GO:0006233 | dTDP biosynthetic process(GO:0006233) dTDP metabolic process(GO:0046072) |
1.0 | 17.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.0 | 3.0 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
1.0 | 12.7 | GO:0070269 | pyroptosis(GO:0070269) |
1.0 | 11.7 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
1.0 | 25.7 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.9 | 12.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.9 | 4.5 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
0.8 | 7.6 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.8 | 9.2 | GO:0034340 | response to type I interferon(GO:0034340) |
0.8 | 11.9 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.8 | 3.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.8 | 16.1 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.8 | 2.3 | GO:1904735 | negative regulation of electron carrier activity(GO:1904733) regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:1904735) negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:1904736) |
0.7 | 13.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.7 | 16.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.7 | 4.6 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.6 | 5.8 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.6 | 10.2 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.6 | 20.2 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.6 | 12.5 | GO:0031000 | response to caffeine(GO:0031000) |
0.6 | 17.2 | GO:0042119 | neutrophil activation(GO:0042119) |
0.5 | 4.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.5 | 11.7 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.5 | 5.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 9.8 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.4 | 16.5 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.4 | 4.7 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.4 | 4.2 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.4 | 2.9 | GO:0007527 | adult somatic muscle development(GO:0007527) |
0.4 | 7.4 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.4 | 1.9 | GO:0031296 | B cell costimulation(GO:0031296) |
0.4 | 12.9 | GO:0046688 | response to copper ion(GO:0046688) |
0.4 | 1.1 | GO:1902867 | negative regulation of neural retina development(GO:0061076) negative regulation of retina development in camera-type eye(GO:1902867) negative regulation of amacrine cell differentiation(GO:1902870) |
0.3 | 2.4 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.3 | 2.9 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.3 | 7.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.3 | 14.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 3.8 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.3 | 14.0 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.3 | 10.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.3 | 3.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 17.2 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.2 | 7.2 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.2 | 11.1 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.2 | 4.3 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.2 | 2.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 7.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.2 | 4.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 5.7 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.2 | 7.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 5.0 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 1.9 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 2.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 3.2 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.1 | 1.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 5.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.7 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.4 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.1 | 1.0 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 4.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 1.3 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 8.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 2.9 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 1.9 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) positive regulation of chromosome segregation(GO:0051984) |
0.1 | 2.9 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 1.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 14.5 | GO:0002250 | adaptive immune response(GO:0002250) |
0.1 | 0.2 | GO:0021634 | optic nerve formation(GO:0021634) optic chiasma development(GO:0061360) regulation of optic nerve formation(GO:2000595) positive regulation of optic nerve formation(GO:2000597) |
0.0 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 12.5 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.0 | 4.9 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.0 | 3.0 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 1.0 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 4.7 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.0 | 0.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 2.8 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 4.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 15.7 | GO:0006935 | chemotaxis(GO:0006935) |
0.0 | 1.6 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 2.0 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.0 | 5.2 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 6.1 | GO:0045087 | innate immune response(GO:0045087) |
0.0 | 3.6 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 1.9 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 0.1 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 41.7 | GO:0042825 | TAP complex(GO:0042825) |
4.3 | 25.7 | GO:0008537 | proteasome activator complex(GO:0008537) |
2.8 | 16.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
2.4 | 16.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
2.3 | 37.0 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
1.8 | 12.7 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
1.7 | 16.6 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
1.6 | 26.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.6 | 4.8 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.6 | 17.1 | GO:0042629 | mast cell granule(GO:0042629) |
1.5 | 4.4 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
1.2 | 5.9 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.8 | 47.0 | GO:0015030 | Cajal body(GO:0015030) |
0.7 | 9.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.7 | 13.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.6 | 5.2 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.6 | 6.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.4 | 6.6 | GO:0044754 | autolysosome(GO:0044754) |
0.4 | 2.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.4 | 15.7 | GO:0035861 | site of double-strand break(GO:0035861) |
0.3 | 46.0 | GO:0016605 | PML body(GO:0016605) |
0.3 | 4.3 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.3 | 8.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 0.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 32.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 5.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 12.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 19.9 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 14.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 5.8 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 87.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 1.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 5.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 2.9 | GO:0070938 | filopodium membrane(GO:0031527) contractile ring(GO:0070938) |
0.1 | 13.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 6.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 135.5 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 4.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 7.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 19.9 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 11.4 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 16.0 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 1.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 11.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 6.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 8.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 4.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 6.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 17.9 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 12.9 | GO:0005635 | nuclear envelope(GO:0005635) |
0.0 | 30.6 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 4.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 8.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 1.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 140.9 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 6.1 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 40.4 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 1.1 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.0 | 1.3 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 2.9 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 23.8 | GO:0005576 | extracellular region(GO:0005576) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.6 | 31.7 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
9.4 | 47.0 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
8.3 | 24.9 | GO:0031726 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) CCR1 chemokine receptor binding(GO:0031726) |
4.8 | 57.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
4.3 | 12.9 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
3.5 | 14.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
3.4 | 17.2 | GO:0019767 | IgE receptor activity(GO:0019767) |
3.3 | 16.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
3.3 | 9.8 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
2.9 | 11.7 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
2.7 | 24.5 | GO:0016936 | galactoside binding(GO:0016936) |
2.7 | 16.1 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
2.5 | 10.0 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
2.3 | 25.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
2.3 | 70.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
2.3 | 25.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
2.2 | 26.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
2.1 | 10.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
2.0 | 5.9 | GO:0005174 | CD40 receptor binding(GO:0005174) |
1.9 | 5.8 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
1.7 | 17.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
1.6 | 13.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.5 | 4.4 | GO:0032139 | DNA polymerase processivity factor activity(GO:0030337) dinucleotide insertion or deletion binding(GO:0032139) |
1.5 | 8.8 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
1.5 | 7.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
1.5 | 5.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.3 | 12.8 | GO:0004064 | arylesterase activity(GO:0004064) |
1.2 | 8.6 | GO:0015265 | urea channel activity(GO:0015265) |
1.2 | 39.8 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
1.1 | 14.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.1 | 10.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
1.1 | 11.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
1.1 | 17.3 | GO:0031386 | protein tag(GO:0031386) |
1.1 | 12.9 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
1.0 | 3.1 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
1.0 | 3.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
1.0 | 16.9 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.9 | 21.6 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.9 | 8.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.8 | 12.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.7 | 4.5 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.7 | 6.7 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.7 | 16.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.6 | 4.4 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.6 | 13.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.6 | 2.9 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.6 | 25.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.6 | 7.4 | GO:0008009 | chemokine activity(GO:0008009) |
0.5 | 7.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 144.8 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.5 | 24.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.4 | 6.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.4 | 2.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.3 | 2.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.3 | 20.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.3 | 1.9 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.3 | 17.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.3 | 14.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 6.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.3 | 1.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 5.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 3.1 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 9.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 45.8 | GO:0004386 | helicase activity(GO:0004386) |
0.2 | 7.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 1.9 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 12.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 67.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 9.8 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
0.2 | 4.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 20.1 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 4.4 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 11.7 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 9.6 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.7 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 5.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 2.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 3.2 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 26.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 1.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 11.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 2.0 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 6.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 7.4 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 14.4 | GO:0015293 | symporter activity(GO:0015293) |
0.1 | 51.2 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 1.3 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 0.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 2.3 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 7.6 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.0 | 44.7 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 4.8 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 4.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 13.4 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 4.1 | GO:0070851 | growth factor receptor binding(GO:0070851) |
0.0 | 0.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 1.0 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 3.6 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 1.2 | GO:0051219 | phosphoprotein binding(GO:0051219) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 30.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.6 | 29.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.6 | 17.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.5 | 16.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 16.9 | PID MYC PATHWAY | C-MYC pathway |
0.4 | 34.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.4 | 28.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 26.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 6.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.3 | 10.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 8.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 7.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 13.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 47.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 7.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 16.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 7.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 24.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 41.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 12.1 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 3.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 10.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 12.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 4.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 5.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 8.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 2.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 11.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 10.3 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 2.0 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 235.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
2.7 | 8.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
2.1 | 40.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.5 | 63.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
1.4 | 12.5 | REACTOME DEFENSINS | Genes involved in Defensins |
1.4 | 22.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
1.3 | 27.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
1.1 | 15.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.0 | 53.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.8 | 10.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.7 | 7.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.7 | 16.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.7 | 56.0 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.7 | 17.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.6 | 39.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.5 | 25.5 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.5 | 8.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.4 | 4.8 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 11.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 3.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.3 | 12.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 13.7 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.3 | 7.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 8.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 5.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 6.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 10.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 4.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 13.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.2 | 8.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 3.8 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 2.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 13.7 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 4.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 3.0 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 5.8 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 2.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 9.2 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |